PBF-1129 in Patients With NSCLC
NCT03274479
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Locally Advanced or Metastatic NSCLC
Interventions
DRUG:
PBF-1129
Sponsor
Palobiofarma SL
Collaborators
[object Object]